Patterns of medication errors involving pediatric population reported to the French Medication Error Guichet

Christine Azar1, Delphine Allué2, Marie B Valnet-Rabier3

  • 1RN, MPH. Epidemiology in Dermatology and Evaluation of therapeutics, Paris-Est Creteil University. Creteil (France). azar.m.christine@gmail.com.

Pharmacy Practice
|July 5, 2021
PubMed

Insights

Pediatric medication errors, particularly with antibacterials and wrong doses, are common in hospitals and communities. This study highlights specific error patterns to improve patient safety and guide future research.

Area of Science:

  • Pharmacovigilance
  • Patient Safety
  • Pediatric Medicine

Background:

  • Medication errors pose a significant global risk to patient safety, especially in pediatric populations.
  • Underreporting and under-research in pediatric medication errors persist in both hospital and community settings.

Purpose of the Study:

  • To analyze and characterize pediatric medication errors reported to the French Medication Error Guichet.
  • To compare pediatric medication errors with those in adults across hospital and community environments.

Main Methods:

  • Retrospective analysis of 4,718 medication error reports from 2013-2017.
  • Descriptive and multivariate analyses comparing pediatric (<18 years) and adult (>18 and <60 years) error reports.
  • Subanalyses focused on actual medication errors with adverse drug reactions (ADRs) and serious ADRs.

Main Results:

  • Antibacterial drugs and wrong dose errors were frequent in pediatric medication errors in both settings.
  • In hospitals, analgesics and blood substitutes were more associated with pediatric errors; serious ADRs involved these and wrong technique/route.
  • In communities, vaccines were the most reported pediatric errors; psycholeptics were linked to serious ADRs, and wrong technique to ADRs.

Conclusions:

  • Distinct pediatric medication error patterns identified in hospital and community settings.
  • Findings support targeted error prevention strategies for pediatric patients.
  • Results provide a foundation for interventional research focused on pediatric medication safety.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
50
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
59
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
59
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
47
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
45
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.3K